Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)

ClinicalTrials.gov ID: NCT04820309

Public ClinicalTrials.gov record NCT04820309. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 9:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in De Novo Subjects With DSM-5 Schizophrenia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 3, multicenter, 56-week, outpatient, open-label (OL) study to evaluate the long-term safety, tolerability, and efficacy of KarXT in de novo subjects with Diagnostic and Statistical Manual-Fifth Edition (DSM-5) schizophrenia. In this OL study, all subjects will receive KarXT (a fixed combination of xanomeline 125 mg and trospium chloride 30 mg twice daily \[BID\]) for up to 52 weeks. The primary objective of the study is to assess the long-term safety and tolerability of KarXT in subjects with a DSM-5 diagnosis of schizophrenia. The secondary objective of this study is to assess the long-term efficacy and characterize the pharmacokinetics of xanomeline and trospium after administration of KarXT.

Study identification

NCT ID
NCT04820309
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
566 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 1, 2021
Primary completion
May 23, 2024
Completion
May 23, 2024
Last update posted
Sep 16, 2025

2021 – 2024

United States locations

U.S. sites
116
U.S. states
22
U.S. cities
59
Facility City State ZIP Site status
Local Institution - 011-238 Little Rock Arkansas 72211-3702
Woodland International Research Group Little Rock Arkansas 72211
Local Institution - 011-201 Rogers Arkansas 72758
Woodland Research Northwest Rogers Arkansas 72758
Local Institution - 011-240 Anaheim California 92805-5854
Advanced Research Center, Inc. Anaheim California 92805
Clinical Innovations, Inc Bellflower California 90706
Local Institution - 011-222 Bellflower California 90706
Local Institution - 011-263 Bellflower California 90706
Local Institution - 011-257 Cerritos California 90703
ATP Clinical Research Inc Costa Mesa California 92626
ATP Clinical Research, Inc. Costa Mesa California 92626
Local Institution - 011-206 Culver City California 90230
ProScience Research Group Culver City California 90230
Local Institution - 011-253 Garden Grove California 92845
Local Institution - 011-202 Glendale California 91206-4282
Behavioral Clinical Research, Inc. Glendale California 91206
Omega Clinical Trials La Habra California 90631-3842
Omega Clinical Trials La Habra California 90631
Alliance for Wellness dba Alliance for Research Long Beach California 90807
Alliance for Wellness Long Beach California 90807
North County Clinical Research (NCCR) Oceanside California 92054
Excell Research Inc Oceanside California 92056
Local Institution - 011-229 Oceanside California 92056
Local Institution - 011-242 Orange California 92868
NRC Research Institute Orange California 92868
CNRI-Los Angeles, LLC Pico Rivera California 90660
Local Institution - 011-244 Pico Rivera California 90660
CITrials Riverside California 92506
Local Institution - 011-233 Riverside California 92506
CITrials Santa Ana California 92705
Local Institution - 011-251 Santa Rosa California 95401-4691
Siyan Clinical Research Santa Rosa California 95401
Local Institution - 011-246 Sherman Oaks California 91403-1747
Schuster Medical Research Institute Sherman Oaks California 91403
Collaborative Neuroscience Research Torrance California 90502
Local Institution - 011-252 Torrance California 90504
Local Institution - 011-224 Hallandale Florida 33009
Velocity Clinical Research, Hallandale Beach Hallandale Florida 33009
Local Institution - 011-261 Hollywood Florida 33024
Homestead Research Institute, Inc. Homestead Florida 33030
Local Institution - 011-231 Homestead Florida 33030
Local Institution - 011-203 Miami Florida 33122-1335
Premier Clinical Research Institute Miami Florida 33122
Central Miami Medical Institute Miami Florida 33125
Local Institution - 011-215 Miami Florida 33125
Local Institution - 011-220 Miami Florida 33165
Phoenix Medical Research Miami Florida 33165
Innovative Clinical Research Miami Lakes Florida 33016
Local Institution - 011-234 Miami Lakes Florida 33016
Research Centers of America at Fort Lauderdale Behavioral Health Center Oakland Park Florida 33334
Health Synergy Clinical Research Okeechobee Florida 34972
Local Institution - 011-216 Okeechobee Florida 34972
Local Institution - 011-219 Pembroke Pines Florida 33024
Pines Care Research Center Pembroke Pines Florida 33024
Local Institution - 011-262 West Palm Beach Florida 33407
Neuroscience Research Institute West Palm Beach Florida 33407
Local Institution - 011-259 Atlanta Georgia 30328
Synexus Clinical Research US, Inc. Atlanta Georgia 30328
Atlanta Center for Medical Research Atlanta Georgia 30331
Local Institution - 011-237 Atlanta Georgia 30331
Local Institution - 011-235 Decatur Georgia 30030-2549
Local Institution - 011-204 Chicago Illinois 60640-5017
Uptown Research Institute Chicago Illinois 60640
Local Institution - 011-223 Wichita Kansas 67214-2878
Ascension Via Christi Research Wichita Kansas 67214
Local Institution - 011-205 Shreveport Louisiana 71101
Louisiana Clinical Research Shreveport Louisiana 71101
CBH Health, LLC Gaithersburg Maryland 20877
Local Institution - 011-211 Gaithersburg Maryland 20877
Local Institution - 011-232 Ann Arbor Michigan 48105-3205
Michigan Clinical Research Institute PC Ann Arbor Michigan 48105
Local Institution - 011-226 Flowood Mississippi 39170
Precise Research Centers Flowood Mississippi 39170
Local Institution - 011-227 Saint Charles Missouri 63304
Midwest Research Group - St. Charles Psychiatric Associates Saint Charles Missouri 63304
St. Charles Psychiatric Associates/Midwest Research Group Saint Charles Missouri 63304
Arch Clinical Trials St Louis Missouri 63118
Local Institution - 011-241 St Louis Missouri 63141
Altea Research Institute Las Vegas Nevada 89102
Local Institution - 011-239 Las Vegas Nevada 89102
Hassman Research Institute Berlin New Jersey 08009
Local Institution - 011-230 Berlin New Jersey 08009
Hassman Research Institute Marlton New Jersey 08053
Local Institution - 011-249 Marlton New Jersey 08053
Local Institution - 011-256 New York New York 10036
Manhattan Behavioral Medicine, PLLC New York New York 10036
Local Institution - 011-210 New York New York 10128
The Medical Research Network, LLC New York New York 10128
Finger Lakes Clinical Research Rochester New York 14618
Local Institution - 011-250 Rochester New York 14618
Clinical Trials of America Hickory North Carolina 28601
Local Institution - 011-218 Dayton Ohio 45417
Midwest Clinical Research Center Dayton Ohio 45417
Local Institution - 011-248 North Canton Ohio 44720
Neuro-Behavioral Clinical Research, Inc North Canton Ohio 44720
Cincy Science West Chester Ohio 45069
Local Institution - 011-221 West Chester Ohio 45069
SP Research PLLC Oklahoma City Oklahoma 73112
Suburban Research Associates Media Pennsylvania 19063
Global Medical Institutes LLC Scranton Medical Institute Moosic Pennsylvania 18507
Local Institution - 011-207 West Chester Pennsylvania 19380
Psychiatric Consultants Franklin Tennessee 37067
Community Clinical Research Austin Texas 78754
Local Institution - 011-243 Austin Texas 78754
BioBehavioral Research of Austin P.C. Austin Texas 78759
BioBehavioral Research of Austin Austin Texas 78759
InSite Clinical Research, LLC DeSoto Texas 75115
Local Institution - 011-236 DeSoto Texas 75115
Local Institution - 011-258 Fort Worth Texas 76104
Core Clinical Research Richmond Texas 77407
healthTx Richmond Texas 77407
Cedar Clinical Research Draper Utah 84020
Local Institution - 011-209 Bellevue Washington 98007-4879
Northwest Clinical Research Center Bellevue Washington 98007
Local Institution - 011-260 Everett Washington 98201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04820309, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 16, 2025 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04820309 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →